Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RESLIZUMAB vs REVLIMID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RESLIZUMAB vs REVLIMID: Safety Overview

Metric RESLIZUMAB REVLIMID
Total FAERS Reports 621 8,878
Deaths Reported 15 1,233
Death Rate 2.4% 13.9%
Hospitalizations 121 3,659
Average Patient Age 55.9 yrs 69.5 yrs
% Female Patients 63.2% N/A
Manufacturer Teva Respiratory, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A